WHCS:SW:SW-iShares MSCI World Health Care Sector ESG UCITS ETF USD Inc USD (USD)

ETF | Others |

Last Closing

USD 7.012

Change

0.00 (0.00)%

Market Cap

USD 0.87B

Volume

0.01M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-05-22 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
CHSRIA:SW UBS ETF (CH) MSCI Switzerland ..

+0.20 (+0.97%)

USD 492,935.36B
XLDX:SW Xtrackers LevDAX Daily Swap UC..

+4.10 (+2.50%)

USD 411,075.38B
CHSRI:SW UBS ETF (CH) - MSCI Switzerlan..

+0.12 (+0.66%)

USD 368,190.74B
XNIF:SW Xtrackers Nifty 50 Swap UCITS ..

-0.05 (-0.02%)

USD 292,109.69B
SWICHA:SW UBS ETF (CH) – MSCI Switzerl..

+0.21 (+0.99%)

USD 226,274.25B
SWUSAH:SW UBS ETF (CH) – MSCI Switzerl..

+0.35 (+1.26%)

USD 226,274.21B
SWEUAH:SW UBS ETF (CH) – MSCI Switzerl..

N/A

USD 226,274.20B
RGLDS:SW Raiffeisen ETF Solid Gold A US..

-92.00 (-1.28%)

USD 134,034.93B
RGLDSH:SW Raiffeisen ETF Solid Gold H CH..

-15.00 (-0.31%)

USD 134,034.91B
RGLDOH:SW Raiffeisen ETF Solid Gold Ounc..

+1.20 (+0.08%)

USD 134,034.86B

ETFs Containing WHCS:SW

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 12 Months  
Capital Gain -0.43% 10% F 16% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -0.43% 10% F 16% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 0.03% 26% F 29% F
Dividend Return 0.03% 26% F 28% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 4.62% 60% D- 65% D
Risk Adjusted Return 0.62% 26% F 28% F
Market Capitalization 0.87B 75% C 71% C-

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.